Literature DB >> 11912254

Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy.

Huaiping Yuan1, Emiko Takeuchi1, Gregory A Taylor1, Margaret McLaughlin1, Dennis Brown1, David J Salant1.   

Abstract

These studies examined the expression of the podocyte slit diaphragm protein nephrin and its association with actin at the onset of proteinuria in passive Heymann nephritis (PHN), a rat model of human membranous nephropathy. Four days after immunization, 58% of PHN rats had mild proteinuria. At that time, most slit diaphragms were still visible on electron microscopy; however, in those locations where the deposits encroached on the filtration slits, the slit diaphragms were either displaced or absent. On day 7, the PHN rats were severely proteinuric, and most slit diaphragms were either absent, displaced, or replaced by occluding-type junctions. Immunofluorescence microscopy with antibodies to the external and cytoplasmic domains of nephrin showed a progressive loss of staining and a change in the distribution of nephrin from an interrupted linear pattern in normal controls to a more dispersed and clustered pattern in PHN. In contrast, the intensity of staining for ZO-1 and CD2-associated protein (CD2AP), two other proteins that are located on the cytoplasmic face of the slit diaphragm, was undiminished. Immunogold electron microscopy confirmed the progressive disappearance of nephrin from podocyte foot processes and retention of CD2AP. Glomeruli and glomerular cell membranes were extracted sequentially with Triton X-100, followed by DNase I or potassium iodide to depolymerize actin. Western blot analysis of the extracts showed a progressive decline of total nephrin on days 4 and 7 of PHN as well as a reduction in the actin-associated fraction. These findings show that nephrin partly dissociates from actin at the onset of podocyte injury in PHN. This is accompanied by a progressive loss of nephrin from the podocyte foot processes and prominent changes in the morphology of the slit diaphragms. These events may underlie the loss of podocyte barrier function in membranous nephropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912254     DOI: 10.1681/ASN.V134946

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 2.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

3.  Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease.

Authors:  K Nagahama; K Maru; S Kanzaki; H L Chai; T Nakai; S Miura; A Yamaguchi; S Yamanaka; Y Nagashima; I Aoki
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 4.  Mechanisms of immune-deposit formation and the mediation of immune renal injury.

Authors:  Masaomi Nangaku; William G Couser
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

5.  Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.

Authors:  Kristina M Niculovic; Linda Blume; Henri Wedekind; Elina Kats; Iris Albers; Stephanie Groos; Markus Abeln; Jessica Schmitz; Esther Beuke; Jan H Bräsen; Anette Melk; Mario Schiffer; Birgit Weinhold; Anja K Münster-Kühnel
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

Review 6.  Therapeutic target for nephrotic syndrome: Identification of novel slit diaphragm associated molecules.

Authors:  Yoshiyasu Fukusumi; Naoko Miyauchi; Taeko Hashimoto; Akira Saito; Hiroshi Kawachi
Journal:  World J Nephrol       Date:  2014-08-06

7.  De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

Authors:  Takamoto Ohse; Michael R Vaughan; Jeffrey B Kopp; Ronald D Krofft; Caroline B Marshall; Alice M Chang; Kelly L Hudkins; Charles E Alpers; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

Review 8.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

Review 9.  Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.

Authors:  Hiroshi Kawachi; Koichi Suzuki; Naoko Miyauchi; Taeko Hashimoto; Yasuhiro Otaki; Fujio Shimizu
Journal:  Clin Exp Nephrol       Date:  2009-03-07       Impact factor: 2.801

10.  Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.

Authors:  Liming Wang; Mathew J Ellis; Timothy A Fields; David N Howell; Robert F Spurney
Journal:  Kidney Blood Press Res       Date:  2008-03-27       Impact factor: 2.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.